These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26012380)

  • 1. Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis.
    Virzì GM; Milan Manani S; Brocca A; Cantaluppi V; de Cal M; Pastori S; Tantillo I; Zambon R; Crepaldi C; Ronco C
    J Nephrol; 2016 Feb; 29(1):111-8. PubMed ID: 26012380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between peritoneal leukocyte count, fluid cultures, and clinical results in peritonitis among peritoneal dialysis patients: is there a geographic or ethnic difference?
    Ozturk S; Sar F; Altas K; Uzun S; Yazici H; Bozfakioglu S; Kazancioglu R
    Adv Perit Dial; 2009; 25():32-40. PubMed ID: 19886314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum.
    Lacquaniti A; Chirico V; Mondello S; Buemi A; Lupica R; Fazio MR; Buemi M; Aloisi C
    J Nephrol; 2013; 26(6):1151-9. PubMed ID: 23807648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis.
    Chimenz R; Lacquaniti A; Colavita L; Chirico V; Fede C; Buemi M; Fede C
    Ren Fail; 2016 Oct; 38(9):1370-1376. PubMed ID: 27499050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis.
    Panorchan K; Davenport A
    BMC Nephrol; 2014 Sep; 15():149. PubMed ID: 25217152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of adipokines in peritoneal effluent: a new marker of acute peritonitis in peritoneal dialysis patients?
    Kolonko A; Chudek J; Wiecek A
    Perit Dial Int; 2008; 28(5):527-32. PubMed ID: 18708547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selection of the optimal method of evaluation of peritonitis risk in patients treated by standard peritoneal dialysis].
    Smoszna J; Raczka A; Fuksiewicz A; Wańkowicz Z
    Pol Arch Med Wewn; 1989 Feb; 81(2):92-9. PubMed ID: 2616362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
    Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
    Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transport status does not predict peritonitis risk in patients on peritoneal dialysis.
    So S; Aw L; Sud K; Lee VW
    Nephrology (Carlton); 2018 Jul; 23(7):633-639. PubMed ID: 28437596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH; Lin CY
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
    Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
    Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.
    Chow KM; Szeto CC; Cheung KK; Leung CB; Wong SS; Law MC; Ho YW; Li PK
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):768-73. PubMed ID: 17699285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients.
    Courivaud C; Bardonnet K; Crepin T; Bresson-Vautrin C; Rebibou JM; Ducloux D
    J Nephrol; 2015 Aug; 28(4):511-5. PubMed ID: 25757532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.
    Korabecna M; Opatrna S; Wirth J; Rulcova K; Eiselt J; Sefrna F; Horinek A
    Ann N Y Acad Sci; 2008 Aug; 1137():296-301. PubMed ID: 18837963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
    Fontán MP; Máñez R; Rodríguez-Carmona A; Peteiro J; Martínez V; García-Falcón T; Domenech N
    Am J Kidney Dis; 2006 Dec; 48(6):972-82. PubMed ID: 17162152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Vychytil A; Herzog R; Probst P; Ribitsch W; Lhotta K; Machold-Fabrizii V; Wiesholzer M; Kaufmann M; Salmhofer H; Windpessl M; Rosenkranz AR; Oberbauer R; König F; Kratochwill K; Aufricht C
    Kidney Int; 2018 Dec; 94(6):1227-1237. PubMed ID: 30360960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in peritoneal dialysis patients.
    Jovanović N; Božinovski SŽ; Krstić S; Obrenović R; Trbojević-Stanković J; Stojimirović B
    Clin Lab; 2014; 60(10):1695-701. PubMed ID: 25651716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.